Department of Cardiology, Heart Lung Center, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands.
Department of Cardiology, Jessa Hospital, Stadsomvaart 11, 3500, Hasselt, Belgium.
Curr Cardiol Rep. 2022 Oct;24(10):1407-1416. doi: 10.1007/s11886-022-01754-w. Epub 2022 Aug 4.
The present article reviews the role of multimodality imaging to improve risk stratification and timing of intervention in patients with valvular heart disease (VHD), and summarizes the latest developments in transcatheter valve interventions.
Growing evidence suggests that intervention at an earlier stage may improve outcomes of patients with significant VHD. Multimodality imaging, including strain imaging and tissue characterization with cardiac magnetic resonance imaging, has the ability to identify early markers of myocardial damage and can help to optimize the timing of intervention. Transcatheter interventions play an increasing role in the treatment of patients who remain at high surgical risk or present at a late stage of their disease. Multimodality imaging identifies markers of cardiac damage at an early stage in the development of VHD. Together with technological innovations in the field of percutaneous valvular devices, these developments have the potential to improve current management and outcomes of patients with significant VHD.
本文综述了多模态影像学在改善瓣膜性心脏病(VHD)患者风险分层和介入时机方面的作用,并总结了经导管瓣膜介入治疗的最新进展。
越来越多的证据表明,早期干预可能改善重度 VHD 患者的预后。多模态影像学,包括应变成像和心脏磁共振成像的组织特征,有能力识别心肌损伤的早期标志物,并有助于优化干预时机。经导管介入在治疗仍处于高手术风险或疾病晚期的患者中发挥着越来越重要的作用。多模态影像学可在 VHD 发展的早期识别心脏损伤的标志物。多模态影像学与经皮瓣膜器械领域的技术创新相结合,有可能改善重度 VHD 患者的现有管理和预后。